Future Market Insights22m
Global Intraocular Lymphoma Therapy Market Poised for Robust Growth, Expected to Reach USD 2.3 Billion by 2033
The global market for intraocular lymphoma therapy is expected to be worth USD 1.2 billion by the year of 2023. The market, ...
Future Market Insights30m
MEA Biologics and Biosimilar Market to Reach USD 875.6 Million by 2033, Fueled by Rising Adoption of Adalimumab | FMI
Abbott Operations Uruguay S.R.L. and Shanghai Henlius Biotech, Inc. entered into a semi-exclusive licensing agreement in May ...